Design and Optimization of 3'-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1'-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors.
ACS Med Chem Lett. 2020 Jan 6;11(3):379-384. doi: 10.1021/acsmedchemlett.9b00495. eCollection 2020 Mar 12.
ACS Med Chem Lett. 2020.
PMID: 32184973